Luncheon November 6, 2015

Celia M. Witten, Ph.D., M.D. CBER's Director, Office of Cellular, Tissue, and Gene Therapy, spoke at an FDAAA lunch on November 6 about advance in gene therapy and how FDA is approaching regulation. This was one of a series of lunches that the FDAAA sponsors during the year, featuring leading FDA officials.